{
  "id": "immunophenotyping",
  "title": "Immunophenotyping",
  "lang": "en",
  "source_lang": "en",
  "summary": "Immunophenotyping identifies and characterizes cell populations by their antigen-expression patterns, commonly using antibody-based methods such as flow cytometry and immunohistochemistry.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Immunophenotypic analysis"
  ],
  "generated_at": "2026-11-05",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/immunophenotyping/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/immunophenotyping/",
      "json": "https://aiwiki.page/zh/immunophenotyping.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Immunophenotyping is the identification and characterization of cells by the pattern of antigens they express, usually detected with labeled antibodies. These antigens are most often proteins on the cell surface or within the cell. Immunophenotyping is widely used to distinguish populations of the immune system, assess cellular differentiation and activation, and characterize abnormal populations. Its principal methods are flow cytometry and immunohistochemistry. Although particularly important in blood and lymphoid tissues, it can also characterize nonhematopoietic cells."
    },
    {
      "heading": "Biological basis",
      "text": "A cell’s immunophenotype is the collection of detectable antigen-expression features used to describe it. It represents one aspect of its phenotype, rather than a complete account of its genetic identity or biological function. Antigen expression varies with cell lineage, developmental stage, activation, tissue environment, and disease.\n\nAn antibody recognizes a particular epitope on its target. Attaching a fluorescent dye, an enzyme-based detection system, or another detectable label to an antibody makes it possible to determine whether that target is present and where it is located. Surface staining detects accessible antigens on the cell membrane. Intracellular staining generally requires fixation and permeabilization so antibodies can reach cytoplasmic or nuclear targets.\n\nMany immune-cell antigens are named using the cluster of differentiation system, abbreviated CD. CD designations identify defined molecules, not cell types: a single CD antigen may occur on several kinds of cells. Consequently, immunophenotyping generally relies on combinations of markers rather than one marker alone.\n\nExamples of commonly used marker combinations include:\n\nCell population | Commonly assessed markers | Important qualification\n[[t-cell | T cells]] | CD3, with CD4 and CD8 for major subsets\n[[b-cell | B cells]] | CD19, CD20, CD79a, and immunoglobulins\n[[natural-killer-cell | Natural killer cells]] | CD56 and/or CD16, with absence of surface CD3\nMonocytes | CD14, CD64, and other myeloid markers | Expression differs among subsets and activation states\n[[hematopoietic-stem-cell | Hematopoietic stem and progenitor cells]] | CD34 and additional lineage-associated markers\n\nThese patterns are contextual rather than universal signatures. Abnormal cells can lose expected antigens, express antigens associated with another lineage, or show unusual combinations and expression intensities."
    },
    {
      "heading": "Main methods",
      "text": "Flow cytometry\n\nFlow cytometry measures individual cells in suspension as they pass through a detection system. Fluorescently labeled antibodies permit simultaneous measurement of multiple antigens, while light-scattering signals provide additional information related to cell size and internal complexity.\n\nAnalysis typically uses gating: selecting groups of events according to measured characteristics. A gating strategy may first exclude debris, cell aggregates, and nonviable cells, then identify leukocytes and progressively narrower populations. Results can include the proportion of a population, marker-expression intensity, and patterns of coexpression on individual cells.\n\nConventional multicolor instruments require compensation for overlapping fluorescence signals. Spectral flow cytometry measures broader emission profiles and uses spectral unmixing to distinguish labels. Both approaches require suitable reference controls and validated analysis procedures.\n\nFlow cytometry is particularly useful for blood, bone marrow, body fluids, and tissues that can be dispersed into cell suspensions. It can analyze large numbers of cells, but routine suspension-based measurements do not preserve their original arrangement within tissue.\n\nImmunohistochemistry and immunofluorescence\n\nImmunohistochemistry detects antigens in tissue sections, commonly through enzyme-linked reactions that produce a visible colored deposit. Immunofluorescence uses fluorescent labels. These approaches show antigen expression together with cellular morphology and tissue architecture.\n\nSpatial context is important when distinguishing reactive immune infiltrates from abnormal tissue populations or determining which cells express a marker. Fixation, embedding, and antigen-retrieval procedures can alter detectability, so staining conditions must be established for each assay.\n\nMultiplex tissue methods detect several markers in the same section or across repeated staining cycles. They extend immunophenotyping to the spatial organization of cell populations, although interpretation depends on image quality, cell segmentation, and the specificity of each marker combination.\n\nMass cytometry and related approaches\n\nMass cytometry uses antibodies labeled with metal isotopes and detects those labels by mass spectrometry. It supports high-dimensional analysis without the fluorescence-emission overlap encountered in optical methods. It nevertheless has its own sources of background, signal interference, and technical variation.\n\nImaging mass cytometry and related techniques retain tissue location while measuring multiple antibody labels. Single-cell methods can also combine antibody-based protein measurements with RNA sequencing. Protein and RNA measurements provide complementary information; transcript abundance is not a direct substitute for antigen detection."
    },
    {
      "heading": "Clinical applications",
      "text": "Hematologic malignancies\n\nImmunophenotyping is central to the characterization of many forms of leukemia and lymphoma. It helps establish lineage, assess maturation, and identify antigen-expression patterns that differ from normal counterparts.\n\nIn acute leukemias, panels commonly examine markers associated with immaturity and myeloid, B-cell, or T-cell differentiation. In mature lymphoid disorders, immunophenotyping helps distinguish populations through their combined antigen patterns. Restricted immunoglobulin light-chain expression can support the identification of a clonal B-cell population, but clonality alone does not establish malignancy.\n\nA diagnosis generally integrates immunophenotyping with clinical findings, cell morphology, tissue architecture, cytogenetics, and molecular results. Some disease categories require particular genetic findings that immunophenotyping cannot establish by itself.\n\nResidual disease assessment\n\nIn selected hematologic cancers, flow-cytometric immunophenotyping is used to detect measurable residual disease: abnormal cells remaining during or after treatment at levels below those readily recognized by routine morphological examination.\n\nTwo complementary strategies are commonly used:\n\n- Leukemia-associated immunophenotype analysis, which tracks an abnormal pattern identified at diagnosis.\n- Different-from-normal analysis, which identifies patterns inconsistent with expected normal maturation.\n\nSensitivity depends on specimen quality, the number of cells examined, the marker panel, and the ability to distinguish abnormal cells from regenerating normal populations. A negative result means that disease was not detected within the assay’s limits; it does not demonstrate that no abnormal cells remain.\n\nImmune-cell enumeration and characterization\n\nImmunophenotyping measures major lymphocyte populations and their subsets, including CD4-positive T cells. It also supports laboratory assessment of immune deficiencies and immune reconstitution after transplantation or other treatments.\n\nPopulation percentages and absolute counts answer different questions. A normal percentage can coexist with a low absolute count if the overall lymphocyte number is reduced. Reference intervals also vary with age, specimen type, and laboratory method."
    },
    {
      "heading": "Research applications",
      "text": "Research immunophenotyping maps the diversity of immune-cell populations and their responses to infection, vaccination, inflammation, and cancer. Panels can examine differentiation, proliferation, cell death, and activation alongside lineage markers.\n\nIntracellular cytokine staining after controlled stimulation characterizes cellular responses under defined experimental conditions. Phosphoprotein measurements can assess signaling states. Such readouts require careful timing and specimen handling because stimulation, fixation, and processing can change the measured phenotype.\n\nHigh-dimensional datasets are analyzed with manual gating, computational clustering, and dimensionality-reduction methods. These methods can reveal populations not anticipated in a predefined gating strategy, but computationally distinct clusters are not automatically distinct biological cell types."
    },
    {
      "heading": "Quality control and interpretation",
      "text": "Reliable immunophenotyping depends on the entire analytical process:\n\n- Specimen handling: Delayed processing, temperature changes, cell loss, and tissue dissociation can change population recovery or antigen expression.\n- Reagent selection: Antibody specificity, clone, concentration, and label influence staining performance.\n- Instrument performance: Calibration, standardized settings, and ongoing quality control support stable measurements.\n- Controls: Unstained, single-label, viability, and fluorescence-minus-one controls address different sources of uncertainty. No single control resolves every interpretive problem.\n- Analysis and reporting: Defined gates, appropriate denominators, and validated thresholds are needed for reproducible results.\n\nFluorescence intensity is not inherently an absolute count of antigen molecules. Quantitative interpretation requires additional standards and assumptions about antibody binding and detection efficiency."
    },
    {
      "heading": "Limitations",
      "text": "An immunophenotype is a measurement of cells under particular sampling and assay conditions, not a permanent identity. Antigen expression can change with activation, disease progression, or treatment. Therapies directed against a surface antigen can also affect its expression or interfere with antibody detection.\n\nSampling introduces further limits. A blood sample may not represent a tissue-localized population, and a small biopsy may miss heterogeneity. Tissue dissociation may preferentially lose fragile or adherent cells. Rare-event analysis is particularly sensitive to contamination, nonspecific staining, and limited cell numbers.\n\nMarker expression alone does not establish every aspect of cellular function. A population expressing activation-associated or inhibitory receptors, for example, may require additional functional or molecular evidence before a particular biological state can be assigned."
    },
    {
      "heading": "Historical development",
      "text": "Immunophenotyping developed from antibody-based microscopy and early cell-surface studies into multiparameter single-cell analysis. The introduction of monoclonal antibody technology in the 1970s made reproducible reagents against defined targets widely available. Subsequent development of the CD classification system standardized the naming of many leukocyte molecules.\n\nAdvances in fluorophores, lasers, detectors, and computing progressively increased the number of markers measurable together. Mass cytometry, spectral flow cytometry, and multiplex tissue imaging later expanded both the dimensionality and spatial scope of antigen-based cell characterization."
    }
  ],
  "links": [
    "cell",
    "antigen",
    "antibody",
    "protein",
    "immune-system",
    "flow-cytometry",
    "immunohistochemistry",
    "phenotype",
    "epitope",
    "cell-membrane",
    "t-cell",
    "b-cell",
    "natural-killer-cell",
    "leukocyte",
    "mass-spectrometry",
    "rna-sequencing",
    "leukemia",
    "lymphoma",
    "diagnosis",
    "cytogenetics",
    "inflammation",
    "cancer",
    "cytokine",
    "calibration"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}